220
Views
0
CrossRef citations to date
0
Altmetric
Case Studies

Case report: Increasing the frequency of intramuscular naltrexone administration in a high risk patient with opioid use disorder

, PharmD, BCPS, BCPPORCID Icon, , M.D.ORCID Icon & , PharmD, BCPS, BCPPORCID Icon

References

  • Hedegaard H, Minino AM, Warner M. Centers for Disease Control and Prevention. Drug overdose deaths in the United States, 1999–2017. National Center for Health Statistics Data Brief No. 329. November 2018.
  • Britton PC, Wines JD, Jr, Conner KR. Non-fatal overdose in the 12 months following treatment for substance use disorders. Drug Alcohol Depend. 2010;107(1):51–55.
  • Latkin CA, Dayton L, Davey-Rothwell MA, Tobin KE. Fentanyl and drug overdose: perceptions of fentanyl risk, overdose risk behaviors, and opportunities for intervention among people who use opioids in Baltimore, USA. Subst Use Misuse. 2019;54(6):998–1006.
  • Centers for Disease Control and Prevention. Fentanyl. National Center for Injury Prevention and Control; May 31, 2019. https://www.cdc.gov/drugoverdose/opioids/fentanyl.html.
  • Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice. Am J Drug Alcohol Abuse. 2012;38(3):187–199.
  • Lee JD, Nunes EV, Novo P, et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. Lancet. 2018;391(10118):309–318.
  • Vivitrol [package insert]. Waltam, MA: Alkermes, Inc; 2010.
  • Luvisi J, Ahonen K, Sethi R. Should long-acting depot intramuscular naltrexone be prescribed every 3 weeks for alcohol use disorder? Prim Care Companion CNS Disord. 2019;21(3):18l02351.
  • American Society of Addiction Medicine. The ASAM National Practice Guideline For the Treatment of Opioid Use Disorder: 2020 Focused Update. Rockville, MD: American Society of Addiction Medicine.
  • Center for Substance Abuse Treatment. Incorporating Alcohol Pharmacotherapies Into Medical Practice. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2009. (Treatment Improvement Protocol (TIP) Series, No. 49.) Chapter 5—extended-release injectable naltrexone.
  • LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
  • Revia [package insert]. Pomona, NY: Duramed Pharmaceuticals, Inc.; 2013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.